Bifogade filer
Kurs
+1,08%
Likviditet
4,08 MSEK
Prenumeration
Kalender
Est. tid* | ||
2026-02-10 | 07:00 | Bokslutskommuniké 2025 |
2025-11-04 | 07:00 | Kvartalsrapport 2025-Q3 |
2025-08-19 | 07:00 | Kvartalsrapport 2025-Q2 |
2025-05-09 | N/A | X-dag ordinarie utdelning BICO 0.00 SEK |
2025-05-08 | N/A | Årsstämma |
2025-04-29 | 07:00 | Kvartalsrapport 2025-Q1 |
2025-02-19 | - | Bokslutskommuniké 2024 |
2024-11-26 | - | Kvartalsrapport 2024-Q3 |
2024-08-20 | - | Kvartalsrapport 2024-Q2 |
2024-05-21 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2024-05-20 | - | Årsstämma |
2024-05-07 | - | Kvartalsrapport 2024-Q1 |
2024-02-20 | - | Bokslutskommuniké 2023 |
2023-11-14 | - | Kvartalsrapport 2023-Q3 |
2023-08-22 | - | Kvartalsrapport 2023-Q2 |
2023-05-10 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2023-05-09 | - | Årsstämma |
2023-05-04 | - | Kvartalsrapport 2023-Q1 |
2023-02-22 | - | Bokslutskommuniké 2022 |
2022-12-14 | - | Extra Bolagsstämma 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-24 | - | Kvartalsrapport 2022-Q2 |
2022-05-18 | - | Kvartalsrapport 2022-Q1 |
2022-04-27 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2022-04-26 | - | Årsstämma |
2022-02-23 | - | Bokslutskommuniké 2021 |
2021-11-17 | - | Extra Bolagsstämma 2021 |
2021-11-10 | - | Kvartalsrapport 2021-Q3 |
2021-08-18 | - | Kvartalsrapport 2021-Q2 |
2021-05-12 | - | Kvartalsrapport 2021-Q1 |
2021-04-27 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2021-04-26 | - | Årsstämma |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-12-18 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2020-12-17 | - | Extra Bolagsstämma 2020 |
2020-10-22 | - | Kvartalsrapport 2020-Q3 |
2020-04-09 | - | Kvartalsrapport 2020-Q2 |
2020-01-20 | - | Kvartalsrapport 2020-Q1 |
2020-01-10 | - | Split BICO 1:4 |
2019-12-19 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2019-12-18 | - | Årsstämma |
2019-10-24 | - | Bokslutskommuniké 2019 |
2019-08-26 | - | Extra Bolagsstämma 2019 |
2019-07-11 | - | Kvartalsrapport 2019-Q3 |
2019-04-10 | - | Kvartalsrapport 2019-Q2 |
2018-12-14 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
2018-12-13 | - | Årsstämma |
2018-10-24 | - | Bokslutskommuniké 2018 |
2018-07-11 | - | Kvartalsrapport 2018-Q3 |
2018-04-11 | - | Kvartalsrapport 2018-Q2 |
2018-01-17 | - | Kvartalsrapport 2018-Q1 |
2017-12-15 | - | X-dag ordinarie utdelning BICO 0.00 SEK |
Beskrivning
Land | Sverige |
---|---|
Lista | Mid Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
BICO Group AB (publ) today publishes Annual and Sustainability Report 2024 on the company’s website.
The Annual and Sustainability Report 2024 is now available digitally in Swedish and an English language version at https://bico.com/investors/financials/financial-reports-and-presentations/.
The Annual Report in accordance with European Single Electronic Format (ESEF) is available in Swedish.
BICO has for sustainability reasons chosen not to print nor distribute hard copies of the report. Those who are unable to access the report digitally can request a print-out by contacting BICO Investor Relations, ir@bico.com.
For further information, please contact:
Maria Forss, President & CEO, BICO Group AB
Phone: EA Isabella Lundin +46 73 515 99 64
E-mail: mf@bico.com
Jacob Thordenberg, Chief Financial Officer, BICO Group AB
Phone: +46 73 534 88 84
E-mail: jt@bico.com
This information is information that BICO Group is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-03-20 09:00 CET.
About BICO
BICO is a lab automation partner and provider of selected workflows to pharma and biotech. With 48,000+ instruments installed in over 65 countries, BICO products, software, and solutions are found in more than 3,500 laboratories, including the world’s top 20 pharmaceutical companies, and have been cited in over 11,900 publications. Operating through three business areas – Lab Automation, Life Science Solutions, and Bioprinting – BICO strives towards the vision to enable and automate the life science lab of the future. BICO is listed on Mid-Cap, Nasdaq Stockholm under BICO. www.bico.com